VKTX - Eli Lilly details NASH effects of weight loss drug
2024-06-05 08:10:19 ET
More on Eli Lilly
- Eli Lilly and Company (LLY) Lilly Oncology ASCO Investor Event (Transcript)
- Eli Lilly's Growth And Challenges: A Cautious Buy
- Eli Lilly: Addressing Supply Challenges Should Accelerate Growth
- Eli Lilly CFO Anat Ashkenazi to resign
- Eli Lilly wins favorable terms for obesity drug use in U.K.